Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Reich

Showing results (51-60 of 90) with videos related to

Pageof 9
Sort By:
Journal of Biomedical Informatics|March 19, 2023
Representing and utilizing clinical textual data for real world studies: An OHDSI approachVipina K Keloth, Juan M Banda, Michael Gurley, et al.
JAMA Pediatrics|May 22, 2023
Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 YearsMao Hu, Hui Lee Wong, Yuhui Feng, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort studyAkihiko Nishimura, Junqing Xie, Kristin Kostka, et al.
Vaccine|February 22, 2024
Incidence rates of thrombosis with thrombocytopenia syndrome (TTS) among adults in United States commercial and Medicare claims databases, 2017-2020Patricia C Lloyd, Bradley Lufkin, Keran Moll, et al.
Frontiers in Pharmacology|October 3, 2022
International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patientsAkihiko Nishimura, Junqing Xie, Kristin Kostka, et al.
Vaccine|October 4, 2022
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 yearsPatricia C Lloyd, Mao Hu, Hui-Lee Wong, et al.
JAMA Network Open|April 24, 2024
Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 YearsMao Hu, Azadeh Shoaibi, Yuhui Feng, et al.
Vaccine|November 20, 2022
Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019-2020Keran Moll, Bradley Lufkin, Kathryn R Fingar, et al.
JAMA Network Open|March 24, 2022
Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational CohortYuan Lu, Mui Van Zandt, Yun Liu, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 11, 2022
Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and EuropeDaniel R Morales, Anna Ostropolets, Lana Lai, et al.
Pageof 9

Showing results (51-60 of 90) with videos related to

Sort By:
Pageof 9
Journal of Biomedical Informatics|March 19, 2023
Representing and utilizing clinical textual data for real world studies: An OHDSI approachVipina K Keloth, Juan M Banda, Michael Gurley, et al.
JAMA Pediatrics|May 22, 2023
Safety of the BNT162b2 COVID-19 Vaccine in Children Aged 5 to 17 YearsMao Hu, Hui Lee Wong, Yuhui Feng, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort studyAkihiko Nishimura, Junqing Xie, Kristin Kostka, et al.
Vaccine|February 22, 2024
Incidence rates of thrombosis with thrombocytopenia syndrome (TTS) among adults in United States commercial and Medicare claims databases, 2017-2020Patricia C Lloyd, Bradley Lufkin, Keran Moll, et al.
Frontiers in Pharmacology|October 3, 2022
International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patientsAkihiko Nishimura, Junqing Xie, Kristin Kostka, et al.
Vaccine|October 4, 2022
Near real-time surveillance of safety outcomes in US COVID-19 vaccine recipients aged 12 to 64 yearsPatricia C Lloyd, Mao Hu, Hui-Lee Wong, et al.
JAMA Network Open|April 24, 2024
Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 YearsMao Hu, Azadeh Shoaibi, Yuhui Feng, et al.
Vaccine|November 20, 2022
Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019-2020Keran Moll, Bradley Lufkin, Kathryn R Fingar, et al.
JAMA Network Open|March 24, 2022
Analysis of Dual Combination Therapies Used in Treatment of Hypertension in a Multinational CohortYuan Lu, Mui Van Zandt, Yun Liu, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|January 11, 2022
Characteristics and outcomes of COVID-19 patients with and without asthma from the United States, South Korea, and EuropeDaniel R Morales, Anna Ostropolets, Lana Lai, et al.
Pageof 9